These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31544308)

  • 1. Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis.
    Cox IJ; Idilman R; Fagan A; Turan D; Ajayi L; Le Guennec AD; Taylor-Robinson SD; Karakaya F; Gavis E; Andrew Atkinson R; Williams R; Sikaroodi M; Nizam S; Gillevet PM; Bajaj JS
    Liver Int; 2020 Feb; 40(2):416-427. PubMed ID: 31544308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort.
    Bajaj JS; Idilman R; Mabudian L; Hood M; Fagan A; Turan D; White MB; Karakaya F; Wang J; Atalay R; Hylemon PB; Gavis EA; Brown R; Thacker LR; Acharya C; Heuman DM; Sikaroodi M; Gillevet PM
    Hepatology; 2018 Jul; 68(1):234-247. PubMed ID: 29350768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stool microbiota show greater linkages with plasma metabolites compared to salivary microbiota in a multinational cirrhosis cohort.
    Cox IJ; Peña Rodríguez M; Fagan A; Rojas-Lara MV; Le Guennec A; Rodriguez-Alvarez F; McGeorge S; Escalona-Nandez I; Torre A; Bajaj JS
    Liver Int; 2022 Oct; 42(10):2274-2282. PubMed ID: 35635305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis.
    Álvares-da-Silva MR; Oliveira CP; Fagan A; Longo L; Thoen RU; Yoshimura Zitelli PM; Tanaka Ferreira RM; Mcgeorge S; Shamsaddini A; Farias AQ; Sikaroodi M; Gillevet PM; Bajaj JS
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):930-940. PubMed ID: 33813071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition and hospitalizations are linked with salivary and faecal microbiota in cirrhosis cohorts from the USA and Mexico.
    Bajaj JS; Torre A; Rojas ML; Fagan A; Nandez IE; Gavis EA; De Leon Osorio O; White MB; Fuchs M; Sikaroodi M; Gillevet PM
    Liver Int; 2020 Jun; 40(6):1395-1407. PubMed ID: 32181561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.
    Bajaj JS; Thacker LR; Fagan A; White MB; Gavis EA; Hylemon PB; Brown R; Acharya C; Heuman DM; Fuchs M; Dalmet S; Sikaroodi M; Gillevet PM
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Effects of Western and Mediterranean-Type Diets on Gut Microbiota: A Metagenomics and Metabolomics Approach.
    Barber C; Mego M; Sabater C; Vallejo F; Bendezu RA; Masihy M; Guarner F; Espín JC; Margolles A; Azpiroz F
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.
    Bajaj JS; Cox IJ; Betrapally NS; Heuman DM; Schubert ML; Ratneswaran M; Hylemon PB; White MB; Daita K; Noble NA; Sikaroodi M; Williams R; Crossey MM; Taylor-Robinson SD; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G951-7. PubMed ID: 25258407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mediterranean Diet on plasma metabolites and their relationship with insulin resistance and gut microbiota composition in a crossover randomized clinical trial.
    Galié S; García-Gavilán J; Papandreou C; Camacho-Barcía L; Arcelin P; Palau-Galindo A; Rabassa A; Bulló M
    Clin Nutr; 2021 Jun; 40(6):3798-3806. PubMed ID: 34130026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Gut Metabolites and Microbial Composition and Functions between Egyptian and U.S. Children Are Consistent with Their Diets.
    Shankar V; Gouda M; Moncivaiz J; Gordon A; Reo NV; Hussein L; Paliy O
    mSystems; 2017; 2(1):. PubMed ID: 28191503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population.
    Bourdeau-Julien I; Castonguay-Paradis S; Rochefort G; Perron J; Lamarche B; Flamand N; Di Marzo V; Veilleux A; Raymond F
    Microbiome; 2023 Feb; 11(1):26. PubMed ID: 36774515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production.
    Wu GD; Compher C; Chen EZ; Smith SA; Shah RD; Bittinger K; Chehoud C; Albenberg LG; Nessel L; Gilroy E; Star J; Weljie AM; Flint HJ; Metz DC; Bennett MJ; Li H; Bushman FD; Lewis JD
    Gut; 2016 Jan; 65(1):63-72. PubMed ID: 25431456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis.
    Bajaj JS; Reddy KR; Tandon P; Garcia-Tsao G; Kamath PS; O'Leary JG; Wong F; Lai J; Vargas H; Thuluvath PJ; Subramanian RM; Pena-Rodriguez M; Sikaroodi M; Thacker LR; Gillevet PM
    Liver Transpl; 2022 Dec; 28(12):1831-1840. PubMed ID: 36017804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
    Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
    Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
    Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
    J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Bajaj JS; Acharya C; Fagan A; White MB; Gavis E; Heuman DM; Hylemon PB; Fuchs M; Puri P; Schubert ML; Sanyal AJ; Sterling RK; Stravitz TR; Siddiqui MS; Luketic V; Lee H; Sikaroodi M; Gillevet PM
    Am J Gastroenterol; 2018 Aug; 113(8):1177-1186. PubMed ID: 29872220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
    Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
    J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.
    Bajaj JS; Betrapally NS; Hylemon PB; Thacker LR; Daita K; Kang DJ; White MB; Unser AB; Fagan A; Gavis EA; Sikaroodi M; Dalmet S; Heuman DM; Gillevet PM
    Sci Rep; 2015 Dec; 5():18559. PubMed ID: 26692421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.